DK1274426T3 - Anvendelse af thioamidoxazolidinoner til behandling af knogleresorption og osteoporose - Google Patents

Anvendelse af thioamidoxazolidinoner til behandling af knogleresorption og osteoporose

Info

Publication number
DK1274426T3
DK1274426T3 DK01926589T DK01926589T DK1274426T3 DK 1274426 T3 DK1274426 T3 DK 1274426T3 DK 01926589 T DK01926589 T DK 01926589T DK 01926589 T DK01926589 T DK 01926589T DK 1274426 T3 DK1274426 T3 DK 1274426T3
Authority
DK
Denmark
Prior art keywords
osteoporosis
treatment
bone resorption
oxazolidinones
thioamide
Prior art date
Application number
DK01926589T
Other languages
English (en)
Inventor
Gebre-Mariam Mesfin
Richard K Jensen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK1274426T3 publication Critical patent/DK1274426T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK01926589T 2000-04-20 2001-04-17 Anvendelse af thioamidoxazolidinoner til behandling af knogleresorption og osteoporose DK1274426T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19868800P 2000-04-20 2000-04-20

Publications (1)

Publication Number Publication Date
DK1274426T3 true DK1274426T3 (da) 2004-06-21

Family

ID=22734385

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01926589T DK1274426T3 (da) 2000-04-20 2001-04-17 Anvendelse af thioamidoxazolidinoner til behandling af knogleresorption og osteoporose

Country Status (14)

Country Link
US (1) US20020010341A1 (da)
EP (1) EP1274426B1 (da)
JP (1) JP2003531167A (da)
AT (1) ATE264101T1 (da)
AU (2) AU5311301A (da)
CA (1) CA2405543A1 (da)
DE (1) DE60102812T2 (da)
DK (1) DK1274426T3 (da)
ES (1) ES2218407T3 (da)
NZ (1) NZ522080A (da)
PT (1) PT1274426E (da)
TR (1) TR200401141T4 (da)
WO (1) WO2001080841A2 (da)
ZA (1) ZA200208269B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2841472B1 (fr) * 2002-06-28 2006-02-24 Agronomique Inst Nat Rech Composition nutritionnelle ou therapeutique contenant le compose hesperidine ou l'un de ses derives
FR2853549B1 (fr) * 2003-04-11 2007-11-09 Agronomique Inst Nat Rech Composition nutritionnelle ou therapeutique contenant le compose oleuropeine ou l'un de ses derives
EP1874782A1 (en) 2005-04-15 2008-01-09 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
EP1899331B1 (en) 2005-06-29 2009-11-25 Pharmacia & Upjohn Company LLC Homomorpholine oxazolidinones as antibacterial agents
WO2008021338A2 (en) 2006-08-15 2008-02-21 Wyeth Tricyclic oxazolidone derivatives useful as pr modulators
FR3005419B1 (fr) 2013-05-13 2015-09-04 Agronomique Inst Nat Rech Utilisation d'une association de deux composes pour le traitement et/ou la prevention de troubles osseux
FR3066919B1 (fr) 2017-06-06 2019-08-02 Institut National De La Recherche Agronomique (Inra) Composition de phycocyanine pour son utilisation pour inhiber la resorption osseuse.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2123889T3 (es) * 1994-11-02 1999-01-16 Merck Patent Gmbh Antagonistas de receptores de adhesion.
DE19516483A1 (de) * 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
BR9815518A (pt) * 1997-05-30 2000-11-21 Upjohn Co Agentes antibacterianos de oxazolidinona tendo funcionalidade de tiocarbonila

Also Published As

Publication number Publication date
EP1274426A2 (en) 2003-01-15
AU5311301A (en) 2001-11-07
CA2405543A1 (en) 2001-11-01
WO2001080841A3 (en) 2002-04-04
JP2003531167A (ja) 2003-10-21
DE60102812D1 (de) 2004-05-19
PT1274426E (pt) 2004-08-31
EP1274426B1 (en) 2004-04-14
TR200401141T4 (tr) 2004-07-21
NZ522080A (en) 2004-04-30
WO2001080841A2 (en) 2001-11-01
DE60102812T2 (de) 2005-06-16
ES2218407T3 (es) 2004-11-16
ATE264101T1 (de) 2004-04-15
US20020010341A1 (en) 2002-01-24
ZA200208269B (en) 2004-02-11
AU2001253113B2 (en) 2005-02-03

Similar Documents

Publication Publication Date Title
DE60213762D1 (de) Implementierung des SHA1 Algorithmusses
DE60140516D1 (de) Behandlung von fluorkohlenstoff- ausgangsmaterialien
DE60114808D1 (de) Oberflächenbehandlung von medizinischer vorrichtung
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
DE60118738D1 (de) Poröses orthopädisches silikon-implantat
ATE498359T1 (de) Chirurgische vorrichtungen
DK1252293T3 (da) Kilde til levervæv
DE60223694D1 (de) Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
DE50214540D1 (de) Stanz bei der behandlung von wunden
CY1107531T1 (el) Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
DK1212317T3 (da) Indolderivater og anvendelse deraf til behandling af osteoporose blandt andre anvendelser
DE60208186D1 (de) Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrinvermittelten erkrankungen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60204584D1 (de) Zusammensetzungen enthaltend eine niedrige konzentration an peroxide zur behandlung von vaginitis
ATE256461T1 (de) Benutzung von comt-inhibitoren als analgetika
DK1274426T3 (da) Anvendelse af thioamidoxazolidinoner til behandling af knogleresorption og osteoporose
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
DK1441761T3 (da) Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
DK1021519T3 (da) Fremgangsmåde til rengøring af kirurgiske instrumenter
DE60223707D1 (de) Calcium-l-threonat zur behandlung von knochenfrakturen
ATE337737T1 (de) Vorrichtung zum knochenaufbau durch distraktion von knochensegmenten
DK1530462T3 (da) 1-phenyl-2-dimethylaminomethylcyclohexanforbindelser til behandling af depressionssymtomer. smerte og inkontinens
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.